HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

Explore homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay in this informative webinar presented by Yann Christinat, PhD and Stephan Bartels, PhD. Learn about this whole-genome microarray research solution and its applications in identifying HRD as a genome-wide biomarker in high-grade ovarian and breast cancers. Discover how PARP inhibitors, a cancer therapeutic class, induce synthetic lethality in tumors with high levels of HRD. Gain valuable insights into the latest advancements in cancer research and potential therapeutic approaches during this 1-hour and 4-minute presentation.